US 12,109,222 B2
Methods and compositions for treating mucositis
William A. Garland, Mountain View, CA (US); Brian D. Frenzel, Mountain View, CA (US); and Philip Liaw, San Jose, CA (US)
Assigned to Tosk, Inc., Mountain View, CA (US)
Filed by Tosk, Inc., Mountain View, CA (US)
Filed on Feb. 12, 2021, as Appl. No. 17/175,258.
Application 17/175,258 is a continuation in part of application No. PCT/US2019/046386, filed on Aug. 13, 2019.
Claims priority of provisional application 62/718,831, filed on Aug. 14, 2018.
Prior Publication US 2021/0236530 A1, Aug. 5, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/7072 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01); A61P 1/04 (2006.01)
CPC A61K 31/7072 (2013.01) [A61K 31/519 (2013.01); A61K 45/06 (2013.01); A61P 1/04 (2018.01)] 20 Claims
 
1. A method of treating a subject for mucositis, the method comprising:
administering to a subject known to be suffering from mucositis an effective amount of a 2,2′-anhydropyrimidine or derivative thereof in combination with an effective amount of uridine to treat the subject for mucositis.